Summit Financial Group, Inc. Announces Conversion of All

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Summit Financial Group, Inc. Announces Conversion of All Its Outstanding Preferred Shares Into Common Stock

MOOREFIELD, W. Va., March 2, 2015 (GLOBE NEWSWIRE) -- Summit Financial Group, Inc. (the "Company") announces that it will be exercising its right to convert all of its outstanding shares of preferred stock into shares of its common stock ("Common Stock") effective as of March 12, 2015.

Pursuant to its articles of incorporation, as amended, and the applicable certificates of designations, the Company has the right to convert the shares of its 8% Non-Cumulative Convertible Preferred Stock, Series 2009, par value of $1.00 per share (the "Series 2009 Preferred Stock"), and the shares of its 8% Non-Cumulative Convertible Preferred Stock, Series 2011, par value of $1.00 per share (the "Series 2011 Preferred Stock," and together with the Series 2009 Preferred Stock, the "Preferred Stock"), upon providing holders with the terms of the conversion that are set forth in this announcement. This announcement serves as the notice that the Company is required to provide holders of Preferred Stock pursuant to each certificate of designation.

The conversion will be consummated on March 12, 2015. Computershare Inc. and its affiliate Computershare Trust Company, N.A. are serving as the conversion agent on behalf of the Company. Holders of Preferred Stock will receive a letter of transmittal from the conversion agent with instructions for surrendering the Preferred Stock certificates for shares of Common Stock. Any questions or requests for assistance concerning the conversion of the Preferred Stock should be directed to Computershare, Inc. at (800) 546-5141 or to Ms. Teresa Ely, Director of Shareholder Relations, at (304) 530-0526 or via e-mail at tely@summitfgi.com.

As of the date hereof, there are 3,610 shares of Series 2009 Preferred Stock outstanding and 11,914 shares of Series 2011 Preferred Stock outstanding.

Each share of Series 2009 Preferred Stock is convertible into 181.8182 shares of Common Stock, plus cash in lieu of any fractional shares, for a total of approximately 656,345 shares of Common Stock to be issued upon conversion.

Each share of Series 2011 Preferred Stock is convertible into 125 shares of Common Stock for a total of 1,489,250 shares of Common Stock to be issued upon conversion.

No fractional shares will be issued as a result of the conversion of the Preferred Stock. Instead, holders will be entitled to receive cash in an amount equal to any fractional shares that they are entitled to receive multiplied by the closing price of the Common Stock on the second trading day prior to the conversion date.

About the Company

Summit Financial Group, Inc. is a $1.44 billion financial holding company headquartered in Moorefield, West Virginia. Summit provides community banking services primarily in the Eastern Panhandle and South Central regions of West Virginia and the Northern and Shenandoah Valley regions of Virginia, through its bank subsidiary, Summit Community Bank, Inc., which operates fifteen banking locations. Summit also operates Summit Insurance Services, LLC in Moorefield, West Virginia and Leesburg, Virginia.

FORWARD-LOOKING STATEMENTS

This press release contains comments or information that constitute forward-looking statements (within the meaning of the Private Securities Litigation Act of 1995) that are based on current expectations that involve a number of risks and uncertainties. Words such as "expects," "anticipates," "believes," "estimates" and other similar expressions or future or conditional verbs such as "will," "should," "would" and "could" are intended to identify such forward-looking statements.

Although we believe the expectations reflected in such forward-looking statements are reasonable, actual results may differ materially. Factors that might cause such a difference include: changes in the financial and securities markets, including changes with respect to the market value of our financial assets; economic and political conditions, especially in the Eastern Panhandle and South Central regions of West Virginia and the Northern and Shenandoah Valley regions of Virginia; real estate prices and sales in the Company's markets; changes in interest rates and interest rate relationships; demand for products and services; the degree of competition by traditional and non-traditional competitors; changes in banking laws and regulations; changes in tax laws; the impact of technological advances; the outcomes of contingencies; trends in customer behavior as well as their ability to repay loans; and changes in the national and local economies. Investors are cautioned not to place undue reliance on forward-looking statements, which speak only as of the date hereof. We undertake no obligation to revise these statements following the date of this press release. Additional information regarding risk factors can be found in the Company's filings with the Securities and Exchange Commission.

Teresa Ely, Director of Shareholder Relations Telephone: (304) 530-0526 Email:

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Novo's Research Unlocks New Insights into Food Noise

Updated Category News Views 223

Unpacking the Science Behind Food Noise When folks think about losing weight, most picture shedding pounds and fitting into those elusive smaller jeans. But get this—there’s a curveball called ‘food noise’ that’s making waves in obesity treatment. Novo Nordisk’s semaglutide injections are shaking things up, cutting down on those persistent thoughts about food....

Continue Reading
CARsgen's CAR-T Breakthrough on China's Insurance List

Updated Category News Views 166

A Game Changer for CAR-T Therapies There's a breeze of optimism blowing from Shanghai these days—a rare sensation in this market of endless skirmishes. CARsgen Therapeutics Holdings Limited, a company entrenched in the development of cutting-edge CAR T-cell therapies, just notched a victory. They've announced that their CAR T-cell therapy product, satricabtagene...

Continue Reading
IEHP's Wellness Center Launch Faces Delay in California

Updated Category News Views 104

Unexpected Delay for IEHP's Community Hub Straight outta Rancho Cucamonga, we've got some news that'll have folks in San Bernardino holding their breath a little longer. The Inland Empire Health Plan (or IEHP if you're part of the 1.4 million served by them) had folks pumped for their new Community Wellness Center. But guess what? They had to slam the brakes on the grand...

Continue Reading
Advanta's Game-Changer: Acquiring Misr Hytech to Expand in Africa

Updated Category News Views 218

Advanta's Strategic Move into Africa Alright, let's cut to the chase. Advanta is making a big splash with its acquisition of Misr Hytech, a move that's going to shake things up in Africa's agricultural sector. This isn't just another merger to gloss over with your morning coffee. We're talking about a deal that's supposed to wrap up by January 31, 2027, bringing together...

Continue Reading
SmallRig Boosts Art-Driven Innovation in AI Era

Updated Category News Views 148

The Interplay of Art and AI In a world where the lines between man and machine blur faster than ever, creators like SmallRig are boldly asking: what role should authenticity play when AI takes the stage? The Shenzhen International Art Museum and SmallRig stood shoulder to shoulder, tackling this head-scrambling question with a global gathering of art and tech giants. It's...

Continue Reading
Beko Pushes for Policy Synergy Amidst Carbon Shakeup

Updated Category News Views 166

When big names like Beko step up on the global stage, you pay attention. During the COP31 panels in Antalya, Türkiye, the company's brass made one thing clear: we need harmony in how climate, trade, and finance policies come together. The stakes? The very strength of industrial competitiveness as new carbon rules turn the heat up on manufacturing practices. The Call for...

Continue Reading
Windward Bio Surges 68% in Nasdaq Debut

Updated Category News Views 243

Windward Bio's Impressive Nasdaq Debut Well, how's that for a debut? Windward Bio, this buzzing clinical-stage biotechnology firm, hit Nasdaq like a storm on November 13, 2026. They priced their IPO at $17.00 per share, but by market close, the stock sat comfortably at $28.50. That's a hearty 68% jump on day one, putting their market value at a sweet $1.69 billion. Behind...

Continue Reading
Webull Faces Class Action: Key Details for Investors

Updated Category News Views 170

What's Really Going on With Webull? When you hear there's a class-action lawsuit brewing, you know something's gone real sideways. Webull Corporation (NASDAQ: BULL) finds itself neck-deep in a securities fraud class action alleging some dicey dealings with China. If you've got skin in the game—and if you bought Webull stock between April 26, 2025, and October 6,...

Continue Reading
LaserAway Expands to 244 Clinics Over 20 Years

Updated Category News Views 186

A Milestone in Aesthetic Dermatology Twenty years, folks. That's a long haul for most businesses, let alone one in the fickle field of aesthetic dermatology. LaserAway, the juggernaut in this arena, has just opened its 244th clinic at 6300 Kingery Hwy in Willowbrook, IL. Nothing to be sneezed at. Imagine running a business, let alone one that's been amping up aesthetic...

Continue Reading
Greenberg Traurig's Brad Kaufman: A Mentor of Resolute Impact

Updated Category News Views 315

A Milestone for Mentorship at Greenberg Traurig In the often cutthroat jungle of law, finding someone who actually gives a damn about you is as rare as finding a unicorn. Yet, there it is—Brad Kaufman, at the helm of Greenberg Traurig's professional development, proving that mentorship can be more than just a checkbox on a quarterly review. Award for Exceptional...

Continue Reading

Top 5 Most Recently Viewed Articles

20th Driskell Prize Gala: Celebrating African American Art

Updated Category News Views 306

The 20th Anniversary of the Driskell Prize Gala The David C. Driskell Prize Gala, often referred to as the "Met Gala of the South," is an extraordinary annual event that grandly honors the recipient of the Driskell Prize in African American Art and Art History. This prize holds the distinguished title of being the first national award recognizing the invaluable...

Continue Reading
Smartsheet Welcomes Eva Schoenleitner as New VP of Partner

Updated Category News Views 273

Smartsheet Strengthens Leadership with New Vice President Smartsheet, a leader in enterprise-grade work management, has made a significant decision in appointing Eva Schoenleitner as their Vice President of Partner. This move highlights the company’s focus on reinforcing their partner ecosystem and driving further growth in the tech industry. Experience That Counts...

Continue Reading
Piedmont Heart Institute Achieves New Heights in Transplants

Updated Category News Views 250

Piedmont Heart Institute Sets New Transplant Record Piedmont Heart Institute recently demonstrated its commitment to advancing cardiac care by achieving a remarkable milestone. In the year 2024, the institute performed 103 heart transplants at Piedmont Atlanta Hospital, establishing a new organizational record. This significant accomplishment underscores the institute's...

Continue Reading
Arizona Metals Corp's Promising Future at Kay Mine Project

Updated Category News Views 222

Arizona Metals Corp Unveils New Mineral Resource Estimate Arizona Metals Corp (TSX: AMC, OTC: AZMCF) has made waves in the mining sector with the recent announcement of its inaugural Mineral Resource Estimate (MRE) for the Kay Mine Project. This project signifies a significant milestone for the company, highlighting its resources and potential for growth. Insights into...

Continue Reading
Leidos Holdings, Inc. Raises Quarterly Cash Dividend Announcement

Updated Category News Views 147

Leidos Holdings, Inc. Announces Increased Dividend Leidos Holdings, Inc. (NYSE: LDOS) has made an exciting announcement regarding its quarterly cash dividend. The company’s board of directors has confirmed a quarterly cash dividend of $0.43 for each outstanding share of its common stock. This marks an increase of $0.03 from the previous dividend of $0.40 per share,...

Continue Reading